Abstract:Modulators of cardiac cyclic adenosine 3’5’-monophosphate (cAMP) and/or its effector protein kinase A (PKA) are used to treat heart disease. Elucidating the mechanisms of endogenous and pharmacological modulators of cAMP, including phosphodiesterase (PDE) inhibitors, is key to predicating alternative drug therapies for heart failure (HF). PDEs regulate confined cAMP/PKA signaling pathways, depending on PDE isoform and localization. PDE3 regulates the SR and sarcolemmal membrane cAMP pools, controlling calcium influx and efflux at these domains. PDE1 regulates sarcolemmal cAMP/PKA signaling. Despite these differences, inhibitors of either increase heart contractility. However, inhibition of PDE3 is pro-arrhythmic, unlike that of PDE1. The regulation of localized cAMP signaling is key to controlled regulation of cell function, with ramifications for HF, and which GPCR lies upstream of PDE1 remains unknown. We hypothesized that the three cAMP-hydrolyzing cardiac PDEs (1, 3, 4) that are found in the human heart would regulate distinct cAMP signaling pathways. Using the cAMP biosensor EPAC-SH187, we performed fluorescence resonance energy transfer experiments in healthy guinea pig adult ventricular myocytes. Cells were treated with inhibitors of PDEs 1, 3, and 4 along with GPCR agonists isoproterenol, glucagon (gcg), and amthamine (amt), respectively for β-adrenergic, gcg and histamine H2 receptors at sub-maximal doses. Cell function and calcium data were obtained using IonOptix. We first asked if PDEi would synergistically regulate pools of cAMP, and found that PDE4i does at pools of cAMP generated by beta-agonism. PDE3i regulates that generated by amt at the H2R, with comparable effects observed in simultaneous or prior H2R stimulation. The combination of these sub-saturating doses exerted strong inotropic and lusitropic effects in paced myocytes. In neither of these domains, PDE1i changed cAMP levels. However, PDE1i intriguingly attenuated the level of gcg-stimulated cAMP production, suggesting a feedback loop mechanism. We conclude that PDEs 1, 3, and 4 regulate distinct pools of cAMP. Importantly, we demonstrate this in a species where the myocardial expression of these PDEs match that of humans as opposed to smaller rodent models.

Different Effects of Dibutyryl Camp on Monolayer Permeability in Human Aortic and Coronary Arterial Endothelial Cells

Effects of Captopril on Vascular Endothelial Cell Morphological and Functional Damages Induced by Oxidized Low Density Lipoproteins

Phosphodiesterase inhibitor modulation of brain microvascular endothelial cell barrier properties.

Effect of PolyI:C on Quantity and Activity of Endothelial Progenitor Cells from Human Umbilical Cord Blood

Effects of Lysophosphatidylcholine on Monolayer Cell Permeability of Human Coronary Artery Endothelial Cells

Exploiting the Cellular Actions of Skca and Ikca Channels to Manipulate Endothelial Function and Vascular Tone

Role of Camp-Dependent Protein Kinase A Activity in Low-Dose Endothelial Monocyte-Activating Polypeptide-II-Induced Opening of Blood–Tumor Barrier

Effects of Peptide Fragments from the Proadrenomedullin on Camp——"the Intramolecular Regulation" of Signal Transduction Pathway in Cells

The Effects of Parathyroid Hormone on L-type Voltage-Dependent Calcium Channel Currents in Vascular Smooth Muscle Cells and Ventricular Myocytes Are Mediated by a Cyclic AMP Dependent Mechanism

Effects of fenoldopam and PBDA on the cAMP generating system in rabbit coronary and renal arteries

Effects of Docosahexaenoic Acid on Large-Conductance Ca2+-Activated K+ Channels and Voltage-Dependent K+ Channels in Rat Coronary Artery Smooth Muscle Cells

Effects of Specific Signal Transduction Inhibitors on Increased Permeability Across Rat Endothelial Monolayers Induced by Neuropeptide Y or VEGF.

Effects of captopril and enalapril on intracellular Ca2+ in vascular smooth muscle cell

Effects of Dihydropyridine Calcium Channel Blockers on Oxidized Low-Density Lipoprotein Induced Proliferation and Oxidative Stress of Vascular Smooth Muscle Cells

[Antagonism of LY333531 on High Glucose Induced Permeability Upregulation of Cardiac Microvascular Endothelial Cells].

Effects of docosahexaenoic acid on large-conductance Ca2+-activated potassium channels in rat coronary artery smooth muscle cells

Effective factors for regulating monolayer permeability of human umbilical vein endothelial cells

Localized Camp-Dependent Signaling Mediates Beta 2-Adrenergic Modulation of Cardiac Excitation-Contraction Coupling.

Low-Dose Endothelial Monocyte-Activating Polypeptide-II Induces Blood–Tumor Barrier Opening Via the cAMP/PKA/Rac1 Pathway

Abstract Mo139: PDE1, 3 and 4 Inhibition and GPCR Agonism in the Regulation of cAMP Signaling

Effects and mechanism analysis of vascular endothelial growth factor and salvianolic acid B on 125I-low density lipoprotein permeability of the rabbit aortary endothelial cells